SEC Form 4 · accession 0001209191-18-013208
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron Cohen
Officer — President and CEO · Director
Period of report
Feb 22, 2018
Accepted (ET)
Feb 26, 2018 · 8:26 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2018 | A | 14,727 | $0.00 | A | 526,375 | D | |
| Common StockF2 | holding | — | — | — | 42,940 | I | Beneficial Ownership in Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the number of shares of the issuer's Common Stock that will be issued to the reporting person based on the vesting of restricted stock units that were previously awarded to the reporting person. The vesting of the shares under the restricted stock units was based on the issuer's achievement of a performance milestone that was specified at the time the restricted stock units were awarded.
- F2These shares are held in a grantor retained annuity trust, which was established by the reporting person and of which he is the sole trustee.